← Back to All Filings

Lam Research Officer Files Form 144 Notice to Sell $17.41M in Common Stock

Medium SignificanceSeptember 2, 2026 at 12:20:59 PM EDT

LAM RESEARCH CORP

$LRCX144CIK: 0000707549

Subscribe to track LRCX

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

📢 Form 144 Filing Notice: Lam Research Corp ($LRCX) • Insider: Varadarajan Seshasayee (Officer) • Proposed Sale: 59,750 Common Shares • Market Value: ~$17,406,370.00 • Approx. Price: ~$291.32 / share • Plan Adoption Date: 05/04/2026 (Rule 10b5-1) • Broker: Fidelity Brokerage Services LLC

Comprehensive Analysis

Executive Summary

On September 2, 2026, Varadarajan Seshasayee, an Officer at LAM RESEARCH CORP ($LRCX), submitted a Form 144 notice declaring an intent to sell 59,750 shares of common stock with an aggregate market value of approximately $17.41 million.

Transaction Breakdown

  • Securities to be Sold: 59,750 Common shares.
    • 20,000 shares originated from restricted stock vesting on March 1, 2026.
    • 39,750 shares acquired via stock option exercise on September 2, 2026.
  • Aggregate Market Value: $17,406,370.00 (~$291.32 per share).
  • Rule 10b5-1 Trading Plan: The sales are scheduled under a pre-established trading plan adopted on May 4, 2026.
  • Broker: Fidelity Brokerage Services LLC.

Market Impact & Context

The planned disposition represents approximately 0.005% of the company's 1,251,321,000 outstanding shares. Given that the transaction is being executed under a Rule 10b5-1 trading plan established four months prior and is tied in part to stock option exercises, market impact is anticipated to be standard and non-disruptive.

Topics:#LRCX#LamResearch#InsiderSelling#Form144#Semiconductors

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.